Sodium Zirconium Cyclosilicate for the Acute Management of Hyperkalemia in the Emergency Department
Annals of Pharmacotherapy · 2025
DOI: 10.1177/10600280251336245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Nicole Gasparovic und 2 weiteren Autor:innen. Beteiligte Einrichtung: Missouri Baptist Medical Center, St. Louis, MO, USA. Hauptthemen laut MEDLINE: Hyperkalemia, Silicates. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
Limited evidence exists examining the use of potassium binders for the acute management of hyperkalemia.
Objective
The objective of the study is to evaluate the use of sodium zirconium cyclosilicate (SZC) for the acute management of hyperkalemia.
Methods
This retrospective cohort study evaluated patients presenting to the emergency department with an initial potassium ≥5.6 mEq/L and treated with the institutional hyperkalemia order set.
Results
Overall, 189 patients were included. There was no significant difference in serum potassium change from baseline to first potassium within 6 hours between the SZC and non-SZC groups (−1.096 ± 0.71 vs −1.067 mEq/L ± 0.81, P = 0.798), respectively. No significant difference was seen between the SZC and non-SZC groups for time from initial hyperkalemia to order set medication administration (1.9 ± 1 vs 2.5 ± 2.9 hours, P = 0.63), mean hospital length of stay (5.5 ± 4.5 vs 6.6 days ± 6.9, P = 0.197), or potassium level at first recheck (5.17 ± 0.68 vs 5.34 mEq/L ± 0.76, P = 0.108). Time from the first medication administration to potassium recheck differed by about 1 hour between groups (4.1 ± 3.1 vs 5.1 hours ± 3.2, P = 0.035), and patients in the SZC group were less likely to have a potassium >6 mEq/L at the first recheck (10.1% vs 21%, P = 0.047). Conclusion and Relevance: The optimal use of SZC in the acute management remains uncertain based on results from this study with no difference in potassium levels at first recheck.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Missouri Baptist Medical Center, St. Louis, MO, USA.
- St. Louis College of Pharmacy, University of Health Sciences and Pharmacy in St. Louis, St. Louis, MO, USA.
ORCID-Profile: Nicole Gasparovic, Amanda Buckallew, Sara Richter
Zitieren
APA
Gasparovic, N., Buckallew, A., & Richter, S. (2025). Sodium Zirconium Cyclosilicate for the Acute Management of Hyperkalemia in the Emergency Department. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251336245
Vancouver
Gasparovic N, Buckallew A, Richter S. Sodium Zirconium Cyclosilicate for the Acute Management of Hyperkalemia in the Emergency Department. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280251336245
BibTeX
@article{Gasparovic2025,
author = {Gasparovic, Nicole and Buckallew, Amanda and Richter, Sara},
title = {Sodium Zirconium Cyclosilicate for the Acute Management of Hyperkalemia in the Emergency Department},
journal = {Annals of Pharmacotherapy},
year = {2025},
doi = {10.1177/10600280251336245}
}
EUVIMED